Products for Research Use Only
RegisterLogin

Avapritinib

CAT: 0026-B2999-5Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0026-B2999-5Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Avapritinib is an inhibitor of oncogenic KIT and PDGFRA mutations. The KIT receptor belongs to the class III receptor tyrosine kinase (RTK) family. Avapritinib potently inhibits the activation loop mutants KIT D816V and PDGFRA D842V and also inhibits other well-characterized disease-driving KIT mutants. It inhibits KIT D816V and PDGFRA D842V with IC₅₀ values of 0.27 nM and 0.24 nM respectively. Avapritinib (0.3-30 mg/kg) reduces tumor volume in a P815 KIT D814Y mastocytoma allograft mouse model and a GIST patient-derived mouse xenograft model in a dose-dependent manner. It has showed marked activity in patients with diseases associated with KIT (aggressive systemic mastocytosis and gastrointestinal stromal tumor) and PDGFRA (gastrointestinal stromal tumor) activation loop mutations in a phase 1 clinical study.
Shipping Conditions
RT
Storage Conditions
-20ºC
Shelf Life
36 months

Alternative Products

CatalogName
206816Avapritinib
CS-O-59037Avapritinib-d6
A19505-50Avapritinib 50mg
A19505-5Avapritinib 5mg
A19505-10Avapritinib 10mg
A19505-1Avapritinib 1mg
CS-O-64315Avapritinib M690

Popular Products